We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Stockholm, Sweden

ESTRO 2026

Session

Monday
May 18
09:00 - 10:00
K2
Breast cancer 4
M. Carmen Rubio Rodríguez, Spain;
Samantha Dicuonzo, Italy
Poster Discussions
Clinical
09:00 - 10:00
Quality Assurance of Radiotherapy in the TAXIS-Trial (OPBC-03): Experiences with Dummy Run Procedures and Consequences for Future Randomized Trials
Guido Henke, Switzerland
-3298
09:00 - 10:00
StrataXRT versus Mepitel Film for prevention of acute radiation dermatitis: pooled intra-patient randomized trials in postmastectomy radiotherapy
Shing Fung Lee, Singapore
-944
09:00 - 10:00
Preoperative radiotherapy in a single fraction for early stage breast cancer: the CRYSTAL phase I/II study update (AIRC IG-23118)
Maria Alessia Zerella, Italy
-728
09:00 - 10:00
Safety and efficacy of StrataXRT for radiation dermatitis in patients with breast cancer: a phase II pilot study (jRCT1032230451)
Takuya Hayashi, Japan
-3336
09:00 - 10:00
Ultra-Hypofractionation adjuvant radiotherapy with simultaneously integrated boost for breast cancer: Long-Term results from a prospective cohort
Maia Dzhugashvili, Spain
-3844
09:00 - 10:00
Single-fraction stereotactic boost in high-risk early breast cancer: safety and early toxicity results of a phase II trial
Giuseppe Facondo, Italy
-2165
09:00 - 10:00
Reported outcomes with three hypofractionated adjuvant radiotherapy schedules in patients with breast cancer.
BUDHI SINGH YADAV, India
-1041
09:00 - 10:00
Phase I Trial Pre-operative Single Fraction Ablative Stereotactic Partial Breast Irradiation (SPBI) Trial for Early Breast Cancer
Asal Rahimi, USA
-4540
09:00 - 10:00
Pathological complete response and postoperative radiation therapy after primary systemic therapy: preliminary results from ReSTORE study
marianna valzano, Italy
-4652
09:00 - 10:00
PROSPECTIVE PHASE II STUDY OF RADIOTHERAPY PLUS CAPACITIVE HYPERTHERMIA IN RECURRENT BREAST CANCER AT THE CATALAN INSTITUTE OF ONCOLOGY (ICO)
Marina Arangüena Peñacoba, Spain
-705